Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Show more

Location: 3052 Orchard Drive, San Jose, CA, 95134, United States | Website: https://www.outsetmedical.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

338M

52 Wk Range

$5.85 - $72.60

Previous Close

$19.07

Open

$19.28

Volume

308,397

Day Range

$19.05 - $19.94

Enterprise Value

251M

Cash

189M

Avg Qtr Burn

-24.01M

Insider Ownership

2.69%

Institutional Own.

83.27%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date